This article reports on a JCO study finding that 40 percent of men with advanced tongue and tonsil cancers were infected with human papillomavirus (HPV). The study's lead author is quoted recommending that the HPV vaccine be considered for male adolescents. The article also mentions another JCO study, which found that people with tumors having high HPV levels were more likely to respond to treatment.
http://www.nytimes.com/2008/05/13/health/13canc.html?_r=1&partner=rssnyt...
Now researchers are finding that many oral cancers in men are also associated with the virus.
A clinical trial testing therapies for advanced tongue and tonsil cancers has found that more than 40 percent of the tumors in men were infected with HPV. If there is good news in the finding, it is that these HPV-associated tumors were among the most responsive to treatment.
Of an estimated 28,900 cases of oral cancer a year, 18,550 are in men.